Total income during Q1 FY22 came down to Rs 2,086.47 crore from Rs 2,171.86 crore in Q1 FY21
For earnings to do well, inflation needs to be in the right zone, albeit this zone is hardly predictable
Provision and contingencies for the quarter ended June 30 came at Rs 4830.80 crore as against Rs 3891.50 crore for the corresponding quarter last year
About 79% say that their earnings would decline this fiscal, while 49% say their savings would decline significantly
It is based on the assumption that the purpose of life insurance is to cover the remaining family members' immediate financial obligations
Revenue from operations was up at Rs 5,183.12 crore during the quarter under review as against Rs 3,883.18 crore in the year-ago period
MRF's consolidated revenue from operations stood at Rs 4,816 crore for the fourth quarter as against Rs 3,685 crore in the same period of FY20
Panacea Biotec's consolidated total income stood at Rs 173.17 crore for the quarter under consideration. It was Rs 143.34 crore for the same period
PVR's total income during the period under review stood at Rs 263.26 crore against Rs 661.78 crore in the corresponding quarter a year ago
CAMS' revenues from operations rose 14.3% to Rs 199.77 crore for the quarter under review from Rs 174.77 crore in the January-March quarter of 2019-20